NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/21/2022
Back to search
Official data from USPTO
JAGUAR GENE THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/21/2022
Trademark type
Combined
Nice classes
42
Filing date
07/13/2020
Registration date
06/21/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/21/2022
Last transaction
06/21/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/25/2021
First use in commerce
02/25/2021
Drawing code
3
Owner type
16
Owner location
Lake Forest, IL, US
Examiner
YOUNG, THOMAS
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized silhouette of the head and upper body parts of a jaguar in profile, with dotted lines extending in the opposite direction of the face in the image, suggesting movement of the animal, and with the word "JAGUAR" in all capitals below the graphic and the words "GENE THERAPY" in all capitals and smaller font below the word "JAGUAR".
Holders and representatives
Holders
Jaguar Gene Therapy, LLC
Representatives
J. Dickson Phillips, III ROBINSON BRADSHAW & HINSON, P.A.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of gene therapy for the treatment of human disease
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/21/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/14/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/13/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/13/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/12/2022
EX2G
SOU EXTENSION 2 GRANTED
05/12/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/12/2022
IUAF
USE AMENDMENT FILED
05/03/2022
EISU
TEAS STATEMENT OF USE RECEIVED
05/03/2022
EXT2
SOU EXTENSION 2 FILED
05/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/26/2021
EX1G
SOU EXTENSION 1 GRANTED
10/22/2021
EXT1
SOU EXTENSION 1 FILED
10/22/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/22/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2021
ALIE
ASSIGNED TO LIE
02/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/13/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/13/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
10/13/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
10/13/2020
DOCK
ASSIGNED TO EXAMINER
10/08/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2020
NWAP
NEW APPLICATION ENTERED
07/16/2020
Continuous trademark protection
Get notified about every new filing that threatens JAGUAR GENE THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.